AI-Driven Drug Discovery: Accelerating Molecular Insights With NVIDIA and Databricks

In the race to revolutionize healthcare and drug discovery, biopharma companies are turning to AI to streamline workflows and unlock new scientific insights. This session, we will explore how NVIDIA BioNeMo, combined with Databricks Delta Lakehouse, can be used for advancing drug discovery for critical applications like molecular structure modeling, protein folding and diagnostics. We’ll demonstrate how BioNeMo pre-trained models can run inference on data securely stored in Delta Lake, delivering actionable insights. By leveraging containerized solutions on Databricks’ ML Runtime with GPU acceleration, users can achieve significant performance gains compared to traditional CPU-based computation.